Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Nanotechnology Could Make a New Generation of Orthopedic Devices Available

By HospiMedica International staff writers
Posted on 25 Feb 2009
Nanoscale oxidative patterning of biocompatible metallic surfaces could lead to superior medical implants that could allow the human body to better accept orthopedic, dental, and cardiovascular metal prostheses.

Researchers at the Université de Montréal (QC, Canada), Plasmionique (Brossard, QC, Canada), the Universidade de São Paulo (Brazil), and other institutions capitalized on recent advances in nanotechnology to change how metals modulate cell activity and development in the body. More...
A critical aspect of the finding is that the metallic surfaces can directly stimulate cells, thereby eliminating the need for pharmaceuticals and their deleterious resulting side effects. The researchers applied chemical compounds to modify the surface of the common biomedical metals--such as titanium--by exposing them to selected etching mixtures of acids and oxidants, which resulted in surfaces with a sponge-like pattern of nano (ultrasmall) pits.

The researchers then tested the effects of the chemically produced nanoporous titanium surfaces on cell growth and development. They showed that the treated surfaces increased growth of bone cells, decreased growth of unwanted cells, and stimulated stem cells, relative to untreated smooth metal surfaces. In addition, expression of genes required for cell adhesion and growth were increased in contact with the nanoporous surfaces. The new technique was described in the January 2009 issue of Nano Letters.

"Using chemical modification, we have produced metals with intelligent surfaces that positively interact with cells and help control the biological healing response,” said senior author Antonio Nanci, Ph.D., a professor at the Université de Montréal's faculty of dentistry. "These will be the building-blocks of new and improved metal implants that are expected to significantly affect the success of orthopedic, dental and cardiovascular prostheses.”

"Our study is groundbreaking,” added Dr. Nanci. "We use simple yet very efficient chemical treatments to alter metals commonly used in the operating room. This innovative approach may ultimately hold the key to developing intelligent materials that are not only easily accepted by the human body but that can actively respond to the surrounding biological environment.”

Related Links:

Université de Montréal
Plasmionique
Universidade de São Paulo




Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Head Rest
Medifa 61114_3
Syringes
Prefilled Saline Flush Syringes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.